In 1901, the Austrian biologist and physician Karl Landsteiner fundamentally transformed medical science by identifying the primary human blood groups. Prior to this discovery, blood transfusions were frequently hazardous and unpredictable, as medical practitioners did not understand why patients often suffered severe and sometimes fatal reactions when receiving blood from others. By categorising human blood into distinct groups, Landsteiner provided the essential scientific explanation for these adverse immune responses, revealing that the success of a transfusion depended entirely on the compatibility between the donor and the recipient.

This breakthrough laid the groundwork for safe clinical practice, enabling the development of rigorous compatibility testing protocols that remain standard in hospitals today. By ensuring that patients receive only matched blood, the medical community was able to mitigate the risks of haemolytic transfusion reactions, which had previously hindered the widespread adoption of the procedure. This advancement proved to be a critical turning point for the evolution of modern healthcare systems.

The identification of blood groups became a cornerstone of medical progress, facilitating significant developments across several vital disciplines:

• The establishment of systematic blood banking and donation programmes.
• The ability to perform complex, life-saving surgical procedures.
• The improvement of emergency care for trauma and haemorrhage patients.
• The advancement of treatments for various blood-related disorders.
• The standardisation of pre-transfusion screening and cross-matching.

Landsteiner's work not only revolutionised the safety of blood transfusions but also paved the way for further research into immunology and genetics. His discovery remains one of the most significant contributions to modern medicine and biotechnology, serving as an enduring foundation for surgical intervention and life-saving medical care worldwide.